Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI

  1. Olga Camacho Vanegas*,,
  2. Enrico Bertini,,§,
  3. Rui-Zhu Zhang,
  4. Stefania Petrini,
  5. Claudia Minosse*,
  6. Patrizia Sabatelli,
  7. Betti Giusti**,
  8. Mon-Li Chu, and
  9. Guglielmina Pepe*,§
  1. *Department of Internal Medicine, University of Rome “Tor Vergata,” Via Tor Vergata 135, 00133 Rome, Italy; Department of Neurosciences, Molecular Medicine, Bambino Gesù Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, 00165 Rome, Italy; Departments of Dermatology and Cutaneous Biology, and Biochemistry and Molecular Pharmacology, Thomas Jefferson University, Philadelphia, PA 19107; Institute of Normal and Pathological Cytomorphology, Consiglio Nazionale delle Ricerche, Istituto Ortopedico Rizzoli (CNR c/o IOR), 40136 Bologna, Italy; and **Department of Medical and Surgical Clinical Care, University of Florence, 50134 Florence, Italy
  1. Edited by Louis M. Kunkel, Harvard Medical School, Boston, MA, and approved April 10, 2001 (received for review January 17, 2001)

Abstract

Ullrich syndrome is a recessive congenital muscular dystrophy affecting connective tissue and muscle. The molecular basis is unknown. Reverse transcription–PCR amplification performed on RNA extracted from fibroblasts or muscle of three Ullrich patients followed by heteroduplex analysis displayed heteroduplexes in one of the three genes coding for collagen type VI (COL6). In patient A, we detected a homozygous insertion of a C leading to a premature termination codon in the triple-helical domain of COL6A2 mRNA. Both healthy consanguineous parents were carriers. In patient B, we found a deletion of 28 nucleotides because of an A → G substitution at nucleotide −2 of intron 17 causing the activation of a cryptic acceptor site inside exon 18. The second mutation was an exon skipping because of a G → A substitution at nucleotide −1 of intron 23. Both mutations are present in an affected brother. The first mutation is also present in the healthy mother, whereas the second mutation is carried by their healthy father. In patient C, we found only one mutation so far—the same deletion of 28 nucleotides found in patient B. In this case, it was a de novo mutation, as it is absent in her parents. mRNA and protein analysis of patient B showed very low amounts of COL6A2 mRNA and of COL6. A near total absence of COL6 was demonstrated by immunofluorescence in fibroblasts and muscle. Our results demonstrate that Ullrich syndrome is caused by recessive mutations leading to a severe reduction of COL6.

Footnotes

  • O.C.V. and E.B. contributed equally to this work.

  • § To whom reprint requests may be addressed. E-mail: guglielmina.pepe{at}bio.uniroma2.it or ebertini{at}tin.it.

  • This paper was submitted directly (Track II) to the PNAS office.

  • Abbreviations:
    CMD,
    congenital muscular dystrophy;
    UCMD,
    Ullrich congenital muscular dystrophy;
    BM,
    Bethlem myopathy;
    COL6,
    collagen VI;
    RT-PCR,
    reverse transcription–PCR;
    CK,
    creatine kinase;
    MRC,
    Medical Research Council
« Previous | Next Article »Table of Contents